Response to MEK Inhibitor Therapy in () K57N Non-Small-Cell Lung Cancer and Genomic Landscape of Mutations in Non-Small-Cell Lung Cancer

Michael L. Cheng, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
Jessica K. Lee, Foundation Medicine, Cambridge, MA.
Rachit Kumar, Harold Alfond Center for Cancer Care, MaineHealth, Augusta, MA.
Harry Klein, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.

Abstract